Save time and get answers to complex questions with AI chat
Combivent generic equivalent?Allergan's patent for latisse expired?When will tenofovir alafenide come off patent in canada?Testosterone enanthate expiration?Does lipitor's effectiveness decrease with high fat meals?
See the DrugPatentWatch profile for pembrolizumab
Pembrolizumab is an antibody that targets the programmed death-1 (PD-1) receptor on immune cells. The ligand for PD-1 is PD-L1 (also called B7-H1). Sources: 1. DrugPatentWatch.com – Pembrolizumab (Keytruda) drug information
Other Questions About Pembrolizumab :